Literature DB >> 2432049

A family of T-cell receptor molecules expressed on T-cell clones with different specificities for allomajor histocompatibility antigens.

J Borst, H Spits, A Voordouw, E de Vries, A Boylston, J E de Vries.   

Abstract

A monoclonal antibody, 3D6, identifies a public idiotope or allotope on the human T-cell receptor for antigen, since it not only reacts with the tumor line HPB-ALL, against which it has been raised, but also with 3-13% of peripheral blood T lymphocytes of normal donors. 3D6+ cells have been isolated from an allogeneic mixed lymphocyte culture and cloned by limiting dilution. In this way, allospecific clones were obtained both of the T4+T8- and the T4-T8+ phenotype, which included proliferative as well as cytotoxic cells. Within a panel of 20 cytotoxic clones, different specificities for both class I and class II MHC antigens were found. The clones were tested for their reactivities with four additional anti-T-cell receptor antibodies raised against HPB-ALL. Two of these, 1C1 and 1C2, reacted with all 3D6+ clones. By means of two other antibodies, 2D4 and 65, the 3D6+ receptor family could be divided into four structurally distinct subfamilies. Biochemical analysis suggested that the 1C1, 1C2, 2D4, and 3D6 antibodies define epitopes on the beta chain of the receptor. Isoelectric focusing of receptor molecules isolated from cytotoxic clones with different specificites indicated that there are extensive structural differences in both alpha and beta chains of the receptors. No correlation could be found between the antigenic specificity of a clone and the structure of its receptor in this analysis. It is postulated that the 1C1, 1C2, and 3D6 epitopes may be encoded by a particular germline V beta segment, in analogy with similar, previously described findings in both the human and the murine system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432049     DOI: 10.1016/0198-8859(86)90302-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  T-cell receptor V beta 5 usage defines reactivity to a human T-cell receptor monoclonal antibody.

Authors:  M Lipoldova; A W Boylston; H Yssel; M J Owen
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  T-cell receptor beta-chain gene usage in the T-cell recognition of Mycobacterium leprae antigens in one tuberculoid leprosy patient.

Authors:  W C van Schooten; J L Ko; N van der Stoep; J B Haanen; L Pickering; R R de Vries; P van den Elsen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  Activation of LFA-1 through a Ca2(+)-dependent epitope stimulates lymphocyte adhesion.

Authors:  Y van Kooyk; P Weder; F Hogervorst; A J Verhoeven; G van Seventer; A A te Velde; J Borst; G D Keizer; C G Figdor
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

4.  Adhesion of T and B lymphocytes to extracellular matrix and endothelial cells can be regulated through the beta subunit of VLA.

Authors:  E van de Wiel-van Kemenade; Y van Kooyk; A J de Boer; R J Huijbens; P Weder; W van de Kasteele; C J Melief; C G Figdor
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

5.  Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody.

Authors:  J Borst; J J van Dongen; R L Bolhuis; P J Peters; D A Hafler; E de Vries; R J van de Griend
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

6.  Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes.

Authors:  P J Peters; J Borst; V Oorschot; M Fukuda; O Krähenbühl; J Tschopp; J W Slot; H J Geuze
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

7.  Extracellular Ca2+ modulates leukocyte function-associated antigen-1 cell surface distribution on T lymphocytes and consequently affects cell adhesion.

Authors:  Y van Kooyk; P Weder; K Heije; C G Figdor
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.